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Mutations in TKT Are the Cause of a Syndrome
Including Short Stature, Developmental Delay,
and Congenital Heart Defects
Lia Boyle,1,9 Mirjam M.C. Wamelink,2,9 Gajja S. Salomons,2 Birthe Roos,2 Ana Pop,2 Andrew Dauber,3
Vivian Hwa,3 Melissa Andrew,3 Jessica Douglas,4 Murray Feingold,4 Nancy Kramer,5 Sulagna Saitta,5
Kyle Retterer,6 Megan T. Cho,6 Amber Begtrup,6 Kristin G. Monaghan,6 Julia Wynn,7
and Wendy K. Chung7,8,*
Whole-exome sequencing (WES) is increasingly being utilized to diagnose individuals with undiagnosed disorders. Developmental delay
and short stature are common clinical indications for WES. We performed WES in three families, using proband-parent trios and two
additional affected siblings. We identified a syndrome due to an autosomal-recessively inherited deficiency of transketolase, encoded
byTKT, on chromosome 3p21. Our series includes three families with a total of five affected individuals, ranging in age from4 to 25 years.
Two families of Ashkenazi Jewish ancestry were homozygous for an 18 base pair in-frame insertion in TKT. The third family was com-
pound heterozygous for nonsense and missense variants in TKT. All affected individuals had short stature and were developmentally
delayed. Congenital heart defects were noted in four of the five affected individuals, and there was a history of chronic diarrhea and
cataracts in the older individuals with the homozygous 18 base pair insertion. Enzymatic testing confirmed significantly reduced trans-
ketolase activity. Elevated urinary excretion of erythritol, arabitol, ribitol, and pent(ul)ose-5-phosphates was detected, as well as elevated
amounts of erythritol, arabitol, and ribitol in the plasma of affected individuals. Transketolase deficiency reduces NADPH synthesis and
nucleic acid synthesis and cell division and could explain the problems with growth. NADPH is also critical for maintaining cerebral
glutathione, whichmight contribute to the neurodevelopmental delays. Transketolase deficiency is one of a growing list of inborn errors
of metabolism in the non-oxidative part of the pentose phosphate pathway.The use of whole-exome sequencing (WES) to diagnose in-
dividuals with undiagnosed disorders, particularly those
that are familial and likely to have an inherited basis, is
increasing in clinical practice.1–3 Developmental delay is
a common clinical indication for WES, due to the genetic
heterogeneity and incomplete knowledge of all the
genes responsible for developmental delay; a definitive
genetic etiology for the developmental delay was found
in 34% of individuals analyzed with clinical WES at one
institution.4
We describe a syndrome identified through WES in five
affected individuals from three unrelated families, all of
whom have proportional short stature, developmental
delay, and congenital heart disease. Transketolase (TKT) is
a reversible, thiamine-dependent enzyme in the pentose
phosphate pathway (PPP) (Figure 1). The PPP consists of
an oxidative phase, which generates NADPH for use in
reductive biosynthesis, and a non-oxidative phase, which
interconverts pentose sugars so they can be used for
nucleotide biosynthesis and as intermediates of the glyco-
lytic pathway. Depending on the cell type and its require-
ment for NADPH, ribose-5P, or ATP, the flow of glucose-6P
is either through the oxidative or the non-oxidative
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in both branches of the pathway (Figure 1). Within the
oxidative branch, glucose 6-phosphate dehydrogenase
(G6PD) is the first enzyme in the pathway. G6PD defi-
ciency is the most common enzyme deficiency in humans
and is associated with hemolysis and jaundice upon expo-
sure to certain foods, illness, and medications.5 Within the
non-oxidative branch, a ribose 5-phosphate isomerase
deficiency was identified in one person presenting with
leukoencephalopathy and peripheral neuropathy.6 Also
within the non-oxidative branch, deficiencies of transaldo-
lase are associated with a variable phenotype that includes
liver disease, hepatosplenomegaly, hemolytic anemia, dys-
morphic features, and congenital heart disease.7–9
We analyzed 2,625 individuals with neurodevelopmen-
tal disorders referred for clinical WES by using the
SureSelect XT2 All Exon V4 or the Clinical Research Exome
kit (Agilent Technologies), comparing both siblings and
their parents. Three probands and two additional family
members from three independent families all had homozy-
gous or compound-heterozygous rare variants in TKT
(MIM: 606781). The parents of all probands gave informed
consent, and the studies were approved by the institu-
tional review board of Columbia University. WES data32, USA; 2Metabolic Unit, Department of Clinical Chemistry, Neuroscience
terdam, the Netherlands; 3Cincinnati Center for Growth Disorders, Division
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Figure 1. Pentitol Pathway
Yellow highlighting reflects the affected TKT enzyme. Metabolites in excess are in red, and deficient metabolites are in blue.were generated, sequences aligned, and variants filtered as
previously described.10 In brief, variants were filtered on
the basis of inheritance patterns, gene lists of interest,
phenotype, and population frequencies (<1%), and were
manually reviewed. Resources including the Human
Gene Mutation Database (HGMD), the 1000 Genomes
database, the NHLBI Exome Variant Server, OMIM,
PubMed, ClinVar, and GeneDx’s internal database were
used to evaluate genes and variants of interest. We
confirmed identified sequence variants of interest with
conventional di-deoxy DNA sequence analysis by using
an ABI3730 (Life Technologies) and a new DNA prepara-
tion for all family members studied.
In the five affected individuals reported, there was an
average of ~13 GB of sequence per sample. Mean coverage
of captured regions was ~1773 per sample, and >98.4% of
the targeted sequenceshadat least 103 coverage, anaverage
of >92% had a base call quality of Q30 or greater, and the
overall average mean quality score was <Q36. A list of the
number of variants for each family after filtering is provided
inTable S1. In family1, bothaffected siblingshave twocom-
pound-heterozygous variants, c.633G>A (p.Trp211Ter) and
c.952C>T (p.Arg318Cys) (GenBank: NM_001135055.2).
The mother is heterozygous for the p.Trp211Ter variant,
and the father is heterozygous for the p.Arg318Cys variant.1236 The American Journal of Human Genetics 98, 1235–1242, JuneThe p.Trp211Ter variant is predicted to lead to nonsense-
mediated decay. The p.Arg318Cys variant is predicted to
be deleterious by SIFT, PolyPhen, CADD, and SVM. In fam-
ilies 2 and 3, both of Ashkenazi heritage, all three affected
individuals are homozygous for c.769_770insCTACCT
CCTTATCTTCTG (p.Trp257delinsSerThrSerLeuSerSerGly),
and parents in both families are heterozygous carriers.
The c.769_770insCTACCTCCTTATCTTCTG TKT variant
(which, for simplicity we refer to as c.769_770ins18) causes
an in-frame deletion of a single conserved tryptophan
residue and an insertion of seven amino acid residues at
codon 257.
The 1000 Genomes database and NHLBI Exome Variant
Server did not detect any of the variants in approximately
6,000 individuals of European and African American
ancestry, in the Database of Single Nucleotide Poly-
morphisms (dbSNP), or in our local database. The
p.Trp257delinsSerThrSerLeuSerSerGly variant and the
p.Trp211Ter variant were not present in the Exome Aggre-
gation Consortium (ExAC) Browser, and the p.Arg318Cys
variant was heterozygous in two individuals of European
ancestry. In our own internal database of 22,700 indi-
viduals sequenced with WES, the p.Trp211Ter variant
was not present, the p.Arg318Cys was seen at 0.01%
frequency (heterozygous in four individuals from two2, 2016
Table 1. Clinical Characteristics of Individuals with Transketolase Deficiency
Family 1 Family 2 Family 3
II.1 II.2 II.1 II.2 II.1
Mutations in TKT c.633G>A, p.Trp211Ter and
c.952C >T, p.Arg318Cys
c.633G>A, p.Trp211Ter and
c.952C>T, p.Arg318Cys
c.769_770ins18,
p.Trp257delinsSerThrSerLeuSerSerGly
c.769_770ins18,
p.Trp257delinsSerThrSerLeuSerSerGly
c.769_770ins18,
p.Trp257delinsSerThrSerLeuSerSerGly
Ancestry European European Russian, Ashkenazi Jewish Russian, Ashkenazi Jewish Ashkenazi Jewish
Sex F F F M F
Current age (years) 8 5 20 11 24
Developmental delay
and/or intellectual
disability
þ (FSIQ ¼ 87, VIQ ¼ 86) þ þ þ þ (FSIQ ¼ 75)
Speech and language delayed speech and language delayed speech non-verbal non-verbal delayed speech
Short stature þ þ þ þ þ
CHD anomalous coronary artery VSD, ASD VSD, PFO, PDA 2 VSDs ASD, VSD
Hypotonia low oral motor tone in infancy   þ þ
Ophthalmic findings   bilateral cataracts, severe
blepharoconjunctuvitis, uveitis
 bilateral cataracts, strabismus,
anterior uveitis
Psychiatric ADHD  stereotypic behavior, self-injurious
behavior, OCD
 ADHD, OCD
Additional phenotypes mild hearing loss  loose stools loose stools, sebhorrheic dermatitis insulin dependent diabetes,
pancreatic exocrine dysfunction,
hepatomegaly, kidney cysts,
secondary amenorrhea
CHD, congenital heart disease; VSD, ventricular septal defect; ASD, atrial septal defect; PDA, patent ductus arteriosus; PFO, patent foramen ovale; ADHD, attention deficit hyperactivity disorder; OCD, obsessive compulsive
disorder; FSIQ, full scale intelligence quotient; VIQ, verbal intelligence quotient; þ, present; , absent.
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Figure 2. Pedigrees and Photographs of Three Families Affected by TKT Variantsseparate European families not in this paper), and the
p.Trp257delinsSerThrSerLeuSerSerGly variant was seen at
0.02% frequency (heterozygous in three individuals from
two separate families not in this paper); of the 1,126
Ashkenazi Jewish adults in the database, two carried one
of these variants, for a carrier frequency of 0.16% in Ashke-
nazi Jews.
The clinical characteristics of the five affected individ-
uals with TKT homozygous or compound-heterozygous1238 The American Journal of Human Genetics 98, 1235–1242, Junevariants are summarized in Table 1, and the pedigrees are
shown in Figure 2. The proband in family 1 (1.II.1) is an
8 year old girl, born at 37 weeks with a birth weight of
2.27 kg (2.1 SD), length of 44.5 cm (2.2 SD), and head
circumference of 31.1 cm (2.3 SD). She had problems
breastfeeding due to low oral motor tone. Developmen-
tally, she was delayed in her early milestones and sat
without support at 7 months, walked at 17.5 months,
and had little speech until three years of age. Due to2, 2016
Table 2. Aberrant Sugar and Polyol Metabolites in Plasma and Deficient Transketolase Enzymatic Activity
Subject
Control ValuesI.1 I.2 II.1 II.2 III.1
Age (years) 8 5 20 11 24 –
Plasma Polyol and Sugar Metabolites (mmol/L)
Threitol <5 <5 6 ([) <5 7 ([) 0–5
Erythritol 28 ([) 28 ([) 60 ([) 28 ([) 56 ([) 0–5
Arabitol 18 ([) 18 ([) 111 ([) 93 ([) 44 ([) 0–5
Ribitol 13 ([) 14 ([) 80 ([) 45 ([) 40 ([) 0–5
Myo-inositol 18 (Y) 17 (Y) 30 19 (Y) 19 (Y) 21–49
Xylulose <5 <5 <5 <5 <5 0–5
Ribose <5 <5 25 ([) 29 ([) interferencea 0–5
Xylitol <5 <5 <5 <5 <5 0–5
Enzyme Studies (nmol/mg Protein/Minute)
Erythrocyte transketolase – – minimal detectable activity minimal detectable activity – –
Lymphoblast transketolase 4.7 4.8 – – – 12.7–31.3
Fibroblast transketolase – – – – no detectable activity 12.1–17.8
Sugars and polyols were analyzed in urine and plasma by gas-chromatography as described.11 Transketolase activity was measured enzymatically in lymphoblast,
fibroblast, and erythrocyte extracts as previously described.12 [, elevated;Y, decreased.
aThe peak in the chromatogram is disturbed by another peak and therefore cannot be quantified.concerns of hyperactivity, distractibility, and speech and
language delays, a formal developmental assessment was
performed at five years of age and demonstrated a full scale
intelligence quotient (FSIQ) of 87, verbal IQ of 86, and pro-
cessing speed of 85. A cardiac echocardiogram was per-
formed after the proband’s sister was born with congenital
heart disease and showed trace aortic regurgitation and a
right coronary artery with an anomalous origin. On
physical examination at 7 years of age, she remained under
the first percentile for weight and height. Growth hor-
mone levels were normal. She is mildly dysmorphic with
hypertelorism. Results of a chromosome microarray were
normal.
The proband’s younger sister (1.II.2) is similarly affected.
She was born at almost 37 weeks with a birth weight of
2.62 kg (1.5 SD), length of 44 cm (2.4 SD), and head
circumference of 31cm (2.4 SD). At birth, she was small
and edematous with anasarca. Cardiac echo showed a
muscular ventricular septal defect, patent ductus arterio-
sus, and an atrial septal defect. Developmentally, she was
delayed and walked at 18 months and talked at 3 years.
At 5 years of age her height and weight are both in the first
percentile. She is mildly dysmorphic with hypertelorism.
The proband in family 2 (2.II.1) is a 20 year old woman,
born at 40 weeks’ gestation with a birth weight of 2.96 kg
(.9 SD), length of 47 cm (1 SD), and head circumference
of 34.3 cm (0.3 SD). In infancy, she was found to have a
ventricular septal defect, patent foramen ovale, and a pat-
ent ductus arteriosus. At 13 years, she developed bilateral
cataracts requiring surgical removal. Additional medical
problems include continued severe blepharoconjunctuvi-The Americtis and uveitis, as well as a history of loose stools. Develop-
mentally, she is significantly delayed and non-verbal with
skills estimated at the level of a 6 year old. She demon-
strates self-injurious and irritable behavior, as well as
stereotypical behavior and obsessive-compulsive ten-
dencies. At 20 years of age, her adult height, weight, and
head circumference are all well below the first percentile,
with a height of 127.9 cm (5.4 SD), weight of 37.6 kg
(3.0 SD), and a head circumference of 51.5 cm
(2.6SD). Growth hormone, growth hormone binding
protein, insulin-like growth factor-1, and insulin-like
growth factor binding protein-3 were all normal. She has
dysmorphic features, including posteriorly rotated ears
with flattened superior helices, broad and full eyebrows
with synophrys, and a mildly flattened nasal bridge with
a slight underbite. A chromosome microarray and molecu-
lar testing for MECP2 were normal.
Her brother (2.II.2) is an 11 year old boy, born at
38.5 weeks’ gestation with a birth weight of 2.89 kg
(1.1 SD) and length of 48.3 cm (0.6 SD). He had two
ventricular septal defects. Additional medical problems
include hypotonia requiring bilateral ankle-foot orthotics,
chronic loose stools, and seborrheic dermatitis. He has se-
vere developmental delay and is non-verbal. At 10 years
and 4 months, his growth was below the first percentile,
with a height of 105.9 cm (5.2 SD), weight of 18 kg
(3.4 SD), and a head circumference of 48 cm (3.8 SD).
He has some mildly dysmorphic features, including a
flattened, broad, and slightly upturned nose, along with
a flattened philtrum and a thin upper lip. The family is
Ashkenazi Jewish.an Journal of Human Genetics 98, 1235–1242, June 2, 2016 1239
Figure 3. Ectopic Expression of TKT Variants Alters TKT Activity
(A) To study the effect of the TKT variants, we constructed two vec-
tors (pCMV6-AN-GFP-TKT [wild-type, WT] and pCMV6-AN-GFP-
TKT Trp257delinsSerThrSerLeuSerSerGly [delins]) and introduced
the missense and nonsense variants in the WT construct.
HEK293 cells were transfected in triplicate with the different
TKTconstructs, with Fugene HD reagent (Promega), and harvested
by trypsinization 24 hr after transfections. To prove the success
of the transient transfections, accumulation of the TKT-GFP
fusion protein was studied by SDS-PAGE and western blotting.
Immunodetection of the TKT-GFP fusion protein was carried out
with rabbit polyclonal anti-GFP primary antibody (Abcam), poly-
clonal goat anti-rabbit immunoglobulins/HRP secondary anti-
body (Dako), and enhanced chemiluminescent substrates (Lumi-
LightPLUS Western Blotting Substrate; Roche Applied Science).
1240 The American Journal of Human Genetics 98, 1235–1242, JuneThe proband in family 3 (3.II.1) is a 24 year old woman,
born full term and small for gestational age with a
birth weight of 2.46 kg (1.8 SD), length of 45.72 cm
(1.6 SD), and a head circumference of 32.8 cm
(1.8 SD). Cardiac septal defects were present at birth. Her
developmental milestones were delayed. She walked at
24 months and talked at 30 months. At 7 years of age, she
was diagnosedwith attention deficit hyperactivity disorder.
When shewas 12, shewasdiagnosedwithbilateral cataracts
and persistent strabismus. At 16, she had a FSIQ of 75,
with immature behavior and demeanor and weaknesses
in reading social cues. She demonstrated perseverative be-
haviors including skin picking and nail biting. At age 18,
she was diagnosed with exocrine pancreatic insufficiency,
pancreatitis, and insulin-dependent diabetes mellitus. She
has persistent hepatomegaly and multiple small kidney
cysts. At age 20, she was diagnosed with anterior uveitis,
with pigment deposits in her lens, reduced visual acuity in
both eyes, and unilateral optic nerve edema. Currently,
she is at or under the first percentile with her weight
(40.23 kg, 3.6 SD), height (128.8 cm, 8 SD), and head
circumference (51.5 cm, 2.6 SD), with a low anterior and
posterior hairline, a prominent forehead, thick hair, prom-
inent eyes, hypotelorism, a broad nasal tip and narrow pal-
ate, small ears, and small hands and feet. Growth hormone
levelswere normal. The family is Ashkenazi Jewish. Shehad
a chromosome microarray analysis that showed a mosaic
23.4 MB interstitial deletion of 13q12.3–13q14.3.
To functionally assess whether these rare variants affect
TKT activity, we directly tested TKT activity in cell extracts
from all five individuals and detected complete absence or
low residual activities (Table 2). We also quantified metab-
olites of the PPP in the urine and plasma. Urinary excretion
of sugars, polyols, and sugar-phosphates wasmeasured and
demonstrated significant elevations of erythritol, arabitol,
ribitol, ribose-5-phosphate, and ribulose/xylulose-5-phos-
phate and mild elevations of ribose, galactitol, and lactose
in individuals 1.II.1, 1.II.2, and 3.II.1 (Table S2). In the
plasma of all individuals, erythritol, arabitol, and ribitol
were elevated and myo-inositol was reduced (Table 2).
To study the effect of the TKT variants, we tran-
siently transfected vectors containing each of the threeWe analyzed all triplicate samples by western blotting for the
presence of the GFP-TKT fusion proteins by using an antibody
against GFP (indicated by arrows). A representative analysis of
the triplicate samples is shown. The fusion protein with an
apparent mass of 75 kDa is present in all transfectants except in
the mock, the untransfected, and the p.Trp211Ter transfected
HEK293 cells. In the latter, degraded TKT fusion proteins are
present.
(B) TKT activity was measured in both untransfected and trans-
fected HEK cells. After 30 min of incubation at 37C, 2.5 mM
ribose-5-phosphate and 0.5 mM xylulose-5-phosphate was added
and the decrease of NADH was photometrically determined.
All transfections were performed in triplicate and TKT activity was
measured in duplicate per transfectant. The activities are corrected
for the basal activity in the mock cells and as the relative activity
compared to theWT transfected HEK293 cells. Error bars represent
the SE of the triplicate transfections.
2, 2016
variants (p.Arg318Cys, p.Trp211Ter, and p.Trp257delins
SerThrSerLeuSerSerGly) in HEK293 cells. Western blotting
confirmed the presence of GFP or GFP-TKT fusion pro-
teins in all transfected cells. The p.Trp211Ter transfected
cells showed degradation of TKT proteins, indicating
nonsense-mediated decay (Figure 3). The missense substi-
tution p.Arg318Cys was found to have residual TKT
activity of 25% when compared to wild-type trans-
fectants, whereas both the p.Trp211Ter and the
p.Trp257delinsSerThrSerLeuSerSerGly transfected cells
had no residual activity. This confirms the pathogenic na-
ture of all three variants.
Possibly, the measured residual activity in erythrocytes
is from another protein with the same function, e.g.,
TKT-like protein (TKTL1 or TKTL2), and these proteins
are not expressed in fibroblasts, explaining why individual
3.II.1 had no detectable TKTactivity in fibroblasts. The low
TKTactivity in some tissues might explain in part why TKT
deficiency is still compatible with life even though TKT is
an essential enzyme.
We describe an inherited genetic disease due to transke-
tolase deficiency and associated with short stature, devel-
opmental delay, and congenital heart disease. TKT is a
thiamine-dependent reversible enzyme in the PPP. TKT
catalyzes the transfer of a two-carbon unit from xylulose-
5-phosphate to one of two substrates: ribose-5-phosphate
producing glyceraldehyde-3-phosphate and sedoheptu-
lose-7-phosphate or erythrose-4-phosphate producing
glyceraldehyde-3-phosphate and fructose-6-phosphate
(Figure 1). The end result of the reaction is the conversion
of the pentose phosphates to intermediates used in the
glycolytic pathway. TKT is an important enzyme of the
PPP, necessary for NADPH synthesis and nucleic acid syn-
thesis and cell division, and might explain the problems
with growth we observe in the individuals reported.
NADPH is also critical for maintaining cerebral gluta-
thione, disturbance of which might contribute to the neu-
rodevelopmental delays.
In all five affected individuals, we demonstrated elevated
concentrations of polyols (erythritol, arabitol, and ribitol)
in urine and plasma and sugar-phosphates (ribose-5-phos-
phate and xylulose/ribulose-5-phosphate) in urine. Other
inborn errors in the PPP, such as RPI and TALDO defi-
ciency, can also lead to accumulation of polyols and
sugar-phosphates, and TALDO deficiency has also been
associated with congenital heart disease, including atrial
septal defect, patent ductus arteriosis, and patent foramen
ovale.9 The source of the accumulated erythritol is un-
known, given that there are no clear elevations of sedohep-
tulose or erythrose-4-phosphate, although this could be
due to the limit of sensitivity of the assay.
Because of the TKT block, xylulose-5-phosphate, ribu-
lose-5-phosphate, and ribose-5-phosphate can only be syn-
thesized via the oxidative branch of the PPP (Figure 1), and
the activity of the non-oxidative branch is markedly
reduced, resulting in a reduced influx of intermediates in
the glycolytic pathway and reduced ATP production.The AmericAfter multiple unsuccessful attempts to create a Tkt
knockout mouse, Xu and colleagues concluded that Tkt-
null embryos die at or before the morula stage.13 40% of
the Tktþ/ mice had 50% of enzymatic activity and ex-
hibited postnatal growth retardation with normal growth
hormone levels. The small female Tktþ/mice had reduced
fertility, markedly reduced adipose tissue, and smaller
livers, kidneys, hearts, and brains.
In animal models, activation of TKT by benfotiamine, a
lipid-soluble thiamine derivative, prevented diabetic reti-
nopathy and inhibited hyperglycemia-induced vascular
damage related to the increased accumulation of glyco-
lytic metabolites.14 It is possible that benfotiamine
could be used therapeutically in individuals with TKT defi-
ciency with some residual activity, and this should be
investigated.
At present, a routine diagnostic work-up of individuals
with short stature, developmental delay, and congenital
heart disease does not include assessment of polyols or
sugar-phosphate, suggesting that other individuals with
TKT deficiency have yet to be diagnosed, particularly in
the Ashkenazi Jewish community. We recommend that
TKT deficiency be included in the differential diagnosis
of children with short stature, developmental delay, and
congenital heart disease.
TKT deficiency is one of a growing list of inborn errors of
metabolism in the non-oxidative portion of the PPP. With
the increase in utilization of WES and other genetic and
metabolic testing, we anticipate that more individuals
might be identified with inborn errors in this pathway,
allowing further elucidation of these phenotypes.Accession Numbers
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